Yifeng Pharmacy Chain Co., Ltd.

SHSE:603939 Stock Report

Market Cap: CN¥27.8b

Yifeng Pharmacy Chain Past Earnings Performance

Past criteria checks 2/6

Yifeng Pharmacy Chain has been growing earnings at an average annual rate of 21.8%, while the Consumer Retailing industry saw earnings growing at 3.5% annually. Revenues have been growing at an average rate of 18.4% per year. Yifeng Pharmacy Chain's return on equity is 15.1%, and it has net margins of 6.4%.

Key information

21.8%

Earnings growth rate

20.7%

EPS growth rate

Consumer Retailing Industry Growth12.8%
Revenue growth rate18.4%
Return on equity15.1%
Net Margin6.4%
Next Earnings Update29 Apr 2025

Recent past performance updates

We Like The Quality Of Yifeng Pharmacy Chain's (SHSE:603939) Earnings

Nov 06
We Like The Quality Of Yifeng Pharmacy Chain's (SHSE:603939) Earnings

Recent updates

We Think Yifeng Pharmacy Chain (SHSE:603939) Can Stay On Top Of Its Debt

Jan 17
We Think Yifeng Pharmacy Chain (SHSE:603939) Can Stay On Top Of Its Debt

Returns On Capital At Yifeng Pharmacy Chain (SHSE:603939) Have Stalled

Dec 12
Returns On Capital At Yifeng Pharmacy Chain (SHSE:603939) Have Stalled

We Like The Quality Of Yifeng Pharmacy Chain's (SHSE:603939) Earnings

Nov 06
We Like The Quality Of Yifeng Pharmacy Chain's (SHSE:603939) Earnings

The Market Lifts Yifeng Pharmacy Chain Co., Ltd. (SHSE:603939) Shares 28% But It Can Do More

Sep 27
The Market Lifts Yifeng Pharmacy Chain Co., Ltd. (SHSE:603939) Shares 28% But It Can Do More

Investors Met With Slowing Returns on Capital At Yifeng Pharmacy Chain (SHSE:603939)

Jul 29
Investors Met With Slowing Returns on Capital At Yifeng Pharmacy Chain (SHSE:603939)

Slammed 27% Yifeng Pharmacy Chain Co., Ltd. (SHSE:603939) Screens Well Here But There Might Be A Catch

Jun 20
Slammed 27% Yifeng Pharmacy Chain Co., Ltd. (SHSE:603939) Screens Well Here But There Might Be A Catch

Yifeng Pharmacy Chain (SHSE:603939) Seems To Use Debt Rather Sparingly

May 24
Yifeng Pharmacy Chain (SHSE:603939) Seems To Use Debt Rather Sparingly

Yifeng Pharmacy Chain's (SHSE:603939) Solid Earnings Are Supported By Other Strong Factors

May 06
Yifeng Pharmacy Chain's (SHSE:603939) Solid Earnings Are Supported By Other Strong Factors

Is Now The Time To Put Yifeng Pharmacy Chain (SHSE:603939) On Your Watchlist?

Apr 13
Is Now The Time To Put Yifeng Pharmacy Chain (SHSE:603939) On Your Watchlist?

Market Participants Recognise Yifeng Pharmacy Chain Co., Ltd.'s (SHSE:603939) Earnings

Mar 28
Market Participants Recognise Yifeng Pharmacy Chain Co., Ltd.'s (SHSE:603939) Earnings

Yifeng Pharmacy Chain Co., Ltd.'s (SHSE:603939) Intrinsic Value Is Potentially 100% Above Its Share Price

Mar 13
Yifeng Pharmacy Chain Co., Ltd.'s (SHSE:603939) Intrinsic Value Is Potentially 100% Above Its Share Price

Revenue & Expenses Breakdown

How Yifeng Pharmacy Chain makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

SHSE:603939 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2423,9191,5236,95743
30 Jun 2423,6441,5056,72841
31 Mar 2423,2931,4826,59839
31 Dec 2322,5881,4126,45434
30 Sep 2322,4271,4376,40427
30 Jun 2321,8431,3916,35926
31 Mar 2321,0041,3306,10126
31 Dec 2219,8861,2625,79325
30 Sep 2217,7361,0165,46520
30 Jun 2216,7309605,17519
31 Mar 2215,8459194,89617
31 Dec 2115,3268884,72116
30 Sep 2114,6468674,43111
30 Jun 2114,1988474,18510
31 Mar 2113,7267983,9489
31 Dec 2013,1457443,7118
30 Sep 2012,3246983,5538
30 Jun 2011,5216373,3757
31 Mar 2010,8555833,2396
31 Dec 1910,2765443,1245
30 Sep 199,6365262,9366
30 Jun 198,9684992,7165
31 Mar 197,9004632,4445
31 Dec 186,9134162,1633
30 Sep 186,0544021,879-2
30 Jun 185,5623841,7220
31 Mar 185,2113451,6060
31 Dec 174,8073141,4960
30 Sep 174,4802851,4092
30 Jun 174,2102671,3260
31 Mar 173,9782411,2500
31 Dec 163,7342241,1700
30 Sep 163,5402101,0850
30 Jun 163,3052001,0020
31 Mar 163,0401879330
31 Dec 152,8461768730
30 Sep 152,6151698060
30 Jun 152,4921617660
31 Mar 152,3731507210
31 Dec 142,2301416780

Quality Earnings: 603939 has high quality earnings.

Growing Profit Margin: 603939's current net profit margins (6.4%) are lower than last year (6.4%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 603939's earnings have grown significantly by 21.8% per year over the past 5 years.

Accelerating Growth: 603939's earnings growth over the past year (6%) is below its 5-year average (21.8% per year).

Earnings vs Industry: 603939 earnings growth over the past year (6%) did not outperform the Consumer Retailing industry 6%.


Return on Equity

High ROE: 603939's Return on Equity (15.1%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/01 20:47
End of Day Share Price 2025/01/27 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Yifeng Pharmacy Chain Co., Ltd. is covered by 23 analysts. 14 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Ethan CuiBofA Global Research
Hao WuChasing Securities
Qianyi LiChina International Capital Corporation Limited